RNA Formulation Solutions
-
mRNA Therapeutics: Development And cGMP Manufacturing
In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.
-
Jet-Based Nanoparticle Formulation At Research Scale
8/14/2025
Developing nanoparticle formulations requires a scalable solution that replicates manufacturing conditions at a small scale. Turbulent jet mixing enables linear scalability while conserving materials.
-
Solutions For mRNA-LNP Vaccine Production And Analysis
12/6/2024
Lipid nanoparticles (LNPs) are a vital part of mRNA vaccines, as they protect the mRNA from degradation and deliver it to the cells. Discover vital solutions for the production and analysis of LNPs.
-
From Plasmid To Fill Finish: Your Dedicated RNA Partner
5/15/2024
One Team, One Roof, One CDMO
Recipharm Advanced Bio's expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.
-
Small is Powerful
Explore best-in-class nanoforming services and how this company works with partners to find ground-breaking solutions that enhance drug effectiveness and targeting.
-
Pre-GMP mRNA And LNP Development
11/26/2024
Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.
-
Single-Use System For Clinical And Commercial Production Of LNPs
7/21/2023
Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.
-
New Solutions For Large Molecule Analysis
6/16/2023
Explore Biozen LC Portfolio
With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:
- Charge Variant Analysis
- Aggregate Analysis
- Peptide Mapping
- Intact Mass Intact and Fragment Analysis
- Glycan Analysis
- Peptide Quantitation
- Drug Antibody Ratio (DAR)
- Oligonucleotide Characterization
-
Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation
7/13/2023
LipidBrick® IM21.7c
- Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
- Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
- Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
-
Contract Services To Optimize Continuous Nanoparticle Processing
10/16/2025
DIANT Pharma provides continuous manufacturing systems and technical services for nanoparticle-based formulations. The company’s platform supports both research and manufacturing teams working on lipid nanoparticles (LNPs), liposomes, polymeric micelles, nucleic acid–lipid complexes, and other colloidal systems.